Organogenesis Holdings Inc. ORGO
$2.32
▼ -1.68% 24H
About
Organogenesis Holdings Inc. is a prominent entity in the biotechnology field, engaged in the development, manufacture, and services related to regenerative medicine products. The company's primary focus is on products that help solve complex medical conditions by harnessing the body's natural ability to repair and rege…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees854
TickerORGO
Statistics
Market Cap$298.5M
Revenue (TTM)$564.2M
Net Income$37.0M
Net Margin6.6%
EPS$0.15
P/E17.07
P/S0.59
P/B1.25
EV/EBITDA11.73
ROE0.7%
Dividend Yield—
Price$2.32
Data: Twelve Data · Revenue = mcap / P/S